Mark Froimson, Director at Pacira BioSciences, Inc. (PCRX), sold 1,468 shares at $72.26 ($106K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $106k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.26 | 734 | $53K | 50.0% |
| 2 | $72.26 | 734 | $53K | 50.0% |
| Total | $72.26 avg | 1,468 | $106K | 100% |
| Filing → |
| PCRX | SELL | 2022-05-11 | $59K | — | Filing → |
| PCRX | BUY | 2017-08-16 | $4K | — | Filing → |